BALYASNY ASSET MANAGEMENT L.P. - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 70 filers reported holding OVID THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$62,064
+5.2%
24,056
-24.7%
0.00%
Q3 2022$59,00031,9380.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,540,671$2,835,0001.27%
Madison Avenue Partners, LP 1,394,022$2,565,0000.55%
BVF INC/IL 6,851,051$12,606,0000.52%
CHI Advisors LLC 864,822$1,591,0000.43%
Rubric Capital Management LP 4,516,300$8,310,0000.42%
EcoR1 Capital, LLC 6,117,400$11,256,0000.33%
Artal Group S.A. 2,500,000$4,600,0000.20%
DCF Advisers, LLC 162,701$299,0000.19%
Oasis Management Co Ltd. 270,000$497,0000.08%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 908,500$1,672,0000.04%
View complete list of OVID THERAPEUTICS INC shareholders